Pharmacogenomics is being implemented now and is already have an impact in the clinical setting and in healthcare. Employing a pharmacogenomics strategy with marketed drugs can mitigate risk by avoiding adverse events, allowing the identification of patients most likely to benefit from a drug, and thereby improving patient compliance and safety. Tangible benefits of pharmacogenomics and resequencing technologies will be presented, and the value of this approach will be demonstrated. The regulatory perspective will be covered from the US, Europe, and Canada. In the future, a confluence of diagnostic testing, drugs and information will be required to bring new medicines to market. This meeting will show how to apply pharmacogenomics to practice.


Application of Pharmacogenomics

If you would like to submit a proposal to give a podium presentation at this meeting, please send us a title and brief, 3-4 sentence summary of a proposed topic on your recent work in the area of the pharmacogenomics. 

The deadline for submission is June 6, 2008. 

Please click here to submit a proposal.

All proposals are subject to review by the Scientific Advisory Committee to ensure the overall quality of the conference program. 

Please note that due to limited speaking slots, preference is given to pharmaceutical and biotech companies. There are limited additional opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

For more information, please contact Christina Lingham at:
Cambridge Healthtech Institute
250 First Avenue Suite 300
Needham, MA 02494
Tel: 781-972-5464
Fax: 781-972-5425
email: clingham@healthtech.com  

For sponsorship or exhibiting information, please contact: 
Arnold Wolfson
Manager, Business Development
Cambridge Healthtech Institute
Phone: 781-972-5431
E-mail: awolfson@healthtech.com